Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: early results of an international phase III study.

Clicks: 259
ID: 272161
2001
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
avril2001lungdocetaxel Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors K Mattson,R Abratt,G.Velde Ten,K Krofta,D Tonelli,I Avril;K Mattson;R Abratt;G.Velde Ten;K Krofta;D Tonelli;I Avril;
Journal lung cancer (amsterdam, netherlands)
Year 2001
DOI
10.1016/s0169-5002(01)00389-0
URL
https://sciprofiles.com/publication/view/7038cbb4b05567b0503795d614fd67f7
Keywords
lung cancer docetaxel adjuvant therapy neo adjuvant international phase treatable stage radically treatable

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.